Full Papers
Microbiota stratification identifies disease-specific alterations in neuro-Behçet’s disease and multiple sclerosis
N. Oezguen1, N. Yalcinkaya2, C.I. Kücükali3, M. Dahdouli4, E.B. Hollister5, R.A. Luna6, R. Türkoglu7, M. Kürtüncü8, M. Eraksoy9, T.C. Savidge10, E. Tüzün11
- Baylor College of Medicine, Department of Pathology & Immunology, and Texas Children's Microbiome Center, Houston TX, USA. oezguen@bcm.edu
- Baylor College of Medicine, Department of Pathology & Immunology, and Texas Children's Microbiome Center, Houston TX, USA.
- Istanbul University, Department of Neuroscience, Institute for Experimental Medical Research, Istanbul, Turkey.
- Baylor College of Medicine, Department of Pathology & Immunology, and Texas Children's Microbiome Center, Houston TX, USA.
- Diversigen, Inc., Houston, TX, USA.
- Baylor College of Medicine, Department of Pathology & Immunology, and Texas Children's Microbiome Center, Houston TX, USA.
- Haydarpasa Numune Training and Research Hospital, Department of Neurology, Istanbul, Turkey.
- Istanbul University, Department of Neuroscience, Institute for Experimental Medical Research, Istanbul, Turkey.
- Istanbul University, Istanbul School of Medicine, Department of Neurology, Istanbul, Turkey.
- Baylor College of Medicine, Department of Pathology & Immunology, and Texas Children's Microbiome Center, Houston TX, USA.
- Istanbul University, Department of Neuroscience, Institute for Experimental Medical Research, Istanbul, Turkey.
CER11936
2019 Vol.37, N°6 ,Suppl.121
PI 0058, PF 0066
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 31172918 [PubMed]
Received: 25/11/2018
Accepted : 28/03/2019
In Press: 30/05/2019
Published: 09/12/2019
Abstract
OBJECTIVES:
Altered gut microbiota community dynamics are implicated in diverse human diseases including inflammatory disorders such as neuro-Behçet’s disease (NBD) and multiple sclerosis (MS). Traditionally, microbiota communities are analysed uniformly across control and disease groups, but recent reports of subsample clustering indicate a potential need for analytical stratification. The objectives of this study are to analyse and compare faecal microbiota community signatures of ethno-geographical, age and gender matched adult healthy controls (HC), MS and NBD individuals.
METHODS:
Faecal microbiota community compositions in adult HC (n=14), NBD patients (n=13) and MS (n=13) were analysed by 16S rRNA gene sequencing and standard bioinformatics pipelines. Bipartite networks were then used to identify and re-analyse dominant compositional clusters in respective groups.
RESULTS:
We identified Prevotella and Bacteroides dominated subsample clusters in HC, MS, and NBD cohorts. Our study confirmed previous reports that Prevotella is a major dysbiotic target in these diseases. We demonstrate that subsample stratification is required to identify significant disease-associated microbiota community shifts with increased Clostridiales evident in Prevotella-stratified NBD and Bacteroides-stratified MS patients.
CONCLUSIONS:
Patient cohort stratification may be needed to facilitate identification of common microbiota community shifts for causation testing in disease.